Physician profile
Amol Madan Takalkar
NPI 1619931060
$8,766.39
in general payments reported to CMS, 2019-2025
12 companies · $926 in 2025
The $926 reported for 2025 was more than what 81% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $62.63 · 2023: $7,479 · 2024: $135 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,063 · Travel and Lodging: $1,613 · Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,063.05 |
| Travel and Lodging | $1,613.39 |
| Food and Beverage | $863.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $6,175.33 | 2023-2024 | |
| Telix Pharmaceuticals | $2,024.47 | 2023-2025 | Illuccix |
| Ge Healthcare | $154.01 | 2023 | |
| Cardiva Medical, INC. | $103.03 | 2019 | |
| Alnylam Pharmaceuticals INC. | $85.71 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $55.98 | 2023 | Cosentyx |
| Eisai INC. | $50.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.86 | 2023-2024 | |
| Cook Medical LLC | $25.31 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.39 | 2019 | |
| Life Molecular Imaging Ltd | $16.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amol Takalkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.